Application of Robotic Stereotactic Radiotherapy to Peripheral Stage I Non-small Cell Lung Cancer with Curative Intent

Clinical Oncology

Volumn 21, Issue 8, 2009, Pages 623-631

  Brown, W T ^a,b   Wu, X ^a,b   Fayad, F ^a   Fowler, J F ^c   Garcia S ^a   Monterroso, M I ^a   de la Zerda, A ^a,b   Schwade, J G ^a,b  

^a CyberKnife Center of Miami   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

CyberKnife; NSCLC; radiotherapy; robotic stereotactic radiotherapy; SBRT

Indexed keywords

GOLD;

ADULT; AGED; ARTICLE; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LINEAR ACCELERATOR; LUNG FUNCTION TEST; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; ROBOTICS; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOSURGERY; ROBOTICS; SURVIVAL ANALYSIS;

EID: 69449104099     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.06.006     Document Type: Article

References (33)

1. Dominioni L., Imperatori A., Rovera F., et al. Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening. Cancer 89 (2000) 2334-2344
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Armstrong J.G., and Minsky B.D. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 16 (1989) 247-255
4. Coy P., and Kennelly G.M. The role of curative radiotherapy in the treatment of lung cancer. Cancer 45 (1980) 698-702
5. Gouders D., Maingon P., Paesmans M., et al. Exclusive radiotherapy for non small cell lung cancer. A retrospective multicentric study. Rep Pract Oncol Radiother (Polish Soc Rad Oncol) 8 (2003) 7-14
6. Kaskowitz L., Graham M.V., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
7. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 40 (1998) 149-154
8. Cesaretti J.A., Pennathur A., Rosenstein B.S., et al. Stereotactic radiosurgery for thoracic malignancies. Ann Thorac Surg 85 (2008) S785-S791
9. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
10. Brown W.T., Wu X., Amendola B., et al. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation-CyberKnife. Cancer J 13 (2007) 87-94
11. Brown W.T., Wu X., Fayad F., et al. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Clin Lung Cancer 8 (2007) 488-492
12. Brown W.T., Wu X., Wen B.C., et al. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors. Comput Aided Surg 12 (2007) 253-261
13. Seppenwoolde Y., Berbeco R.I., Nishioka S., et al. Accuracy of tumor motion compensation algorithm from a robotic respiratory tracking system: a simulation study. Med Phys 34 (2007) 2774-2784
14. Wong K.H., Dieterich S., Tang J., et al. Quantitative measurement of CyberKnife robotic arm steering. Technol Cancer Res Treat 6 (2007) 589-594
15. Nioutsikou E., Seppenwoolde Y., Symonds-Tayler J.R., et al. Dosimetric investigation of lung tumor motion compensation with a robotic respiratory tracking system: an experimental study. Med Phys 35 (2008) 1232-1240
16. Ho A.K., Fu D., Cotrutz C., et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery 60 (2007) ONS147-ONS156 (discussion ONS156)
17. Muacevic A., Staehler M., Drexler C., et al. Technical description, phantom accuracy, and clinical feasibility for fiducial-free frameless real-time image-guided spinal radiosurgery. J Neurosurg Spine 5 (2006) 303-312
18. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
19. Fowler J.F., Tome W.A., Fenwick J.D., et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
20. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
21. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 49 (2001) 23-33
22. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
23. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
24. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
25. Blomgren H., Lax I., Naslund I., et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34 (1995) 861-870
26. Wulf J., Baier K., Mueller G., et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
27. Wulf J., Hadinger U., Oppitz U., et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655
28. Wulf J., Haedinger U., Oppitz U., et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 (2004) 186-196
29. Collins B.T., Erickson K., Reichner C.A., et al. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol 2 (2007) 39
30. Roth JA, Chang JY, Komaki R. International randomized study to compare CyberKnife stereotactic radiotherapy with surgical resection in stage I non-small cell lung cancer (Lung Cancer STARS Trial). 7th Annual CyberKnife Users' Meeting Scottsdale, Arizona, 2008.
31. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015-1024
32. Grills I.S., Fitch D.L., Goldstein N.S., et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 334-341
33. Seppenwoolde Y., De Jaeger K., Boersma L.J., et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 748-758